Case study · Hormone HealthSample
OngoingRising hematocrit three months into testosterone therapy
Age 50–59Sex: MaleTRT / Hormone Health
KP
Founder, hormone & longevity clinic
Hematocrit question for the hormone folks. Rising HCT three months into therapy; split dosing is helping. Where do you draw the line between adjusting and pausing?
- Presenting issue
- Symptomatic low testosterone confirmed on two morning draws; started weekly injections. Hematocrit 53% at the three-month check.
- Approach
- Split to twice-weekly dosing at the same weekly total; hydration counselling; sleep apnea screening; repeat labs at six weeks.
- Outcome Ongoing
- Hematocrit 50% at six weeks. Sleep study pending.
The author asks
At what hematocrit do you pause therapy rather than adjust dosing?
De-identified · attested by the author on October 24, 2026
The author confirmed this case contains no patient identifiers: no names, initials, record numbers, exact dates or locations smaller than a state. Ages are shown as ranges. If you spot something that could identify a patient, report it — those reports go to the top of the moderation queue.
188241 saves